Ask Warren

Shinpoong Pharmaceutical

019170 · KOSPI · ₩019170 · 신풍제약

₩8,350▼ ₩60 (0.71%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩235B₩221B₩200B₩209B₩189B
Cost of sales₩132B₩139B₩120B₩131B₩112B
Gross profit₩103B₩82B₩80B₩78B₩77B
Operating income₩14B−₩20B−₩47B−₩34B−₩14B
Net income₩8.4B−₩15B−₩57B−₩35B−₩12B
Net income to shareholders₩8.8B−₩15B−₩57B−₩35B−₩12B

Balance sheet

20252024202320222021
Total assets₩352B₩342B₩350B₩362B₩398B
Current assets₩207B₩189B₩199B₩197B₩233B
Cash and equivalents₩47B₩42B₩44B₩42B₩28B
Total liabilities₩82B₩84B₩79B₩31B₩38B
Current liabilities₩67B₩76B₩76B₩27B₩29B
Borrowings₩55B₩52B₩45B₩13B₩248M
Total equity₩271B₩258B₩271B₩331B₩360B
Shareholders' equity₩270B₩257B₩270B₩330B₩359B

Cash flow

20252024202320222021
Cash from operations₩17B−₩15B−₩25B−₩26B−₩71B
Capital spending₩3.5B₩5.6B₩15B₩5.3B₩4.4B
Free cash flow₩14B−₩21B−₩40B−₩32B−₩75B
Dividends paid₩0—₩0—₩5.2B

Consolidated where available. Amounts in won.

Also known as: Shinpoong Pharmaceutical / 신풍제약 / 019170 / KRX:019170

Source: KRX statistical information